Literature DB >> 3034630

The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.

P A Loo, A F Braunwalder, M Williams, M A Sills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034630     DOI: 10.1016/0014-2999(87)90624-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain.

Authors:  X M Gao; C A Tamminga
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine.

Authors:  I J Reynolds; S N Murphy; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801.

Authors:  J S Hahn; E Aizenman; S A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?

Authors:  A Jackson; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.

Authors:  L J Herberg; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Biologically active MK-801 and SKF-10,047 binding sites distinct from those in rat brain are expressed on human lung cancer cells.

Authors:  R Maneckjee; J D Minna
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

Review 7.  Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands.

Authors:  P C Contreras; J B Monahan; T H Lanthorn; L M Pullan; D A DiMaggio; G E Handelmann; N M Gray; T L O'Donohue
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.